An E-platform for Learners

Day: September 28, 2025

Pumitamig Delivers Promising Efficacy with Positive PFS Trend in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Pumitamig Delivers Promising Efficacy with Positive PFS Trend in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Pharm'Up

Interim data from a global, randomized Phase 2 clinical trial (NCT06449209) on pumitamig (BNT327, BMS986545; Bristol Myers...

Health Equity Crisis: Black Adults Hospitalized for Heart Failure Nearly 14 Years Earlier Than White Counterparts

Health Equity Crisis: Black Adults Hospitalized for Heart Failure Nearly 14 Years Earlier Than White Counterparts

Pharm'Up

A groundbreaking study by Northwestern Medicine investigators, published in the Journal of the American College of Cardiology,...

Paltusotine Makes History as First Oral, Once-Daily Treatment for Acromegaly

Paltusotine Makes History as First Oral, Once-Daily Treatment for Acromegaly

Pharm'Up

The FDA has approved paltusotine (Palsonify; Crinetics Pharmaceuticals, Inc), marking a historic milestone as the first once-daily,...

Critical Delay: High LDL-C Detection and the Elevated Risk of Heart Attack

Critical Delay: High LDL-C Detection and the Elevated Risk of Heart Attack

Pharm'Up

A retrospective study published in the European Heart Journal reveals that a delayed initiation of statin therapy...

Empowering the Front Line: How Pharmacists Can Revolutionize Immunization Access for Vulnerable Cancer Patients

Empowering the Front Line: How Pharmacists Can Revolutionize Immunization Access for Vulnerable Cancer Patients

Pharm'Up

Patients battling cancer are profoundly immunosuppressed due to their chemotherapy and other therapeutic regimens, placing them at...

IMS 2025: On-Body Injector (OBI) Technology Streamlines Oncology Care, Enhancing Safety and Efficiency for Pharmacists and Nurses

IMS 2025: On-Body Injector (OBI) Technology Streamlines Oncology Care, Enhancing Safety and Efficiency for Pharmacists and Nurses

Pharm'Up

At the 22nd annual International Myeloma Society (IMS) meeting, Xavier Leleu, MD, PhD, a leading hematologist from...

Alarming Rise in Pediatric Flu-Linked Neurological Complications Underscores Urgent Need for Vaccination

Alarming Rise in Pediatric Flu-Linked Neurological Complications Underscores Urgent Need for Vaccination

Pharm'Up

The 2024-25 U.S. flu season witnessed a deeply concerning surge in neurological complications among children infected with...

Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes

Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes

Pharm'Up

Biolinq Inc. has achieved a significant milestone in diabetes management with the FDA granting De Novo classification...

Collaborative Care and Pharmacist-Led Management of CDK4/6 Inhibitor Toxicities

Collaborative Care and Pharmacist-Led Management of CDK4/6 Inhibitor Toxicities

Pharm'Up

In the evolving landscape of HR-positive/HER2-negative breast cancer, Cyclin-Dependent Kinase 4/6 (CDK4/6) inhibitors have cemented their role...

Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma

Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma

Pharm'Up

New data presented at the 2025 International Myeloma Society Annual Meeting in Toronto, Canada, has revealed that...